RE:RE:RE:RE:RE:RE:RE:RE:RE:U of Toledo Confirmation TrialsThanks OTC. Despite my poor attempts at humor, I really believe TLT has a unique technology that can effectively eliminate many solid tumors. My main concern is that in poor financial markets, credit will disappear no matter how promising the technology. Therefore, I see it as critical that TLT focus. Per their recent SEDAR update, it now appears that we're at least 9 months away from the ph1/2 trial start up. The only interim catalyst to reinforce the technology is an independent confirmation of the animal data per U of Toledo. As far as Bencro is concerned, he continually regurgitates old information and/or comes up with new, pie in the sky uses for lasers, much of which other suppliers could easily achieve. TLT has a unique laser + PDC combination and that needs to be the focus... the only focus. They have to have the cash 9 months from now to at least begin the trials and that is not a sure thing right now in my mind. I don't expect the recent market sell off lately to be an issue this year but feel that by mid- 2015, we could have a real market sell off. TLT needs to get that trial off the ground with a sense of urgency. The U of T data will provide the only real lift between now and then.